Skip to content
Biodatica
Start free

Investigator

Monica Kraft

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · funded by OD, NHLBI, NIAID

Companies
2

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$3.5M

Summed across those awards.

First award
Jun 1, 2016

Latest Jun 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. OT2

    All of Us Research Program New York Consortium

    $500k

    Jun 1, 2024ODICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11333562 (opens the source filing in a new tab)

  2. OT2

    All of Us Research Program New York Consortium

    $600k

    Jun 1, 2024ODICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11526616 (opens the source filing in a new tab)

  3. R38

    Mount Sinai StARR Program - NHLBI

    $346k

    Feb 1, 2024NHLBIICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11009567 (opens the source filing in a new tab)

  4. U19

    Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection

    $487k

    Jun 1, 2016NIAIDUNIVERSITY OF ARIZONANIH RePORTER · 11132932 (opens the source filing in a new tab)

  5. U19

    Innate Immunity and Viral Infection in Asthma

    $1.4M

    Jun 1, 2016NIAIDUNIVERSITY OF ARIZONANIH RePORTER · 11132917 (opens the source filing in a new tab)

  6. U19

    Administrative Core

    $150k

    Jun 1, 2016NIAIDUNIVERSITY OF ARIZONANIH RePORTER · 11132918 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources